Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists who analyzed tumor cells that proved resistant to the original treatment. ...
Oct 25, 2021
0
8
As perceived by both patients and doctors, the cosmetic results after "lumpectomy" for breast cancer differ for African-American versus Caucasian women, suggests a pilot study in the Plastic and Reconstructive Surgery—Global ...
Jan 8, 2014
0
0
Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated with neoadjuvant chemotherapy (NAC) had a higher score of a biomarker of distant metastatic recurrence than ...
Dec 6, 2022
0
2
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan ...
Apr 9, 2013
0
1
Increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs reduced the risk of early-stage breast ...
Dec 6, 2017
0
1
For young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at least in the shorter term.
May 4, 2023
0
4
Stress stimulates the formation of blood vessels in bone and may help breast cancer cells to invade this organ.
Aug 10, 2017
0
0
Among premenopausal women with hormone receptor (HR)-positive, early-stage breast cancer enrolled in the SOFT trial, those with a high score on a genomic assay called Breast Cancer Index (BCI) had increased risk of distant ...
Dec 6, 2022
0
12
Pfizer Inc. says the Food and Drug Administration will let the drugmaker apply for approval of its heavily touted experimental breast cancer medicine based on midstage patient testing results.
May 16, 2014
0
0
Patient-reported outcome (PRO) data indicates that partial breast irradiation (PBI) is more convenient than whole breast irradiation (WBI) for women with breast cancer who do not receive adjuvant chemotherapy. These participants ...
Jun 3, 2019
0
0
